×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

POINT Biopharma Global Inc. (PNT) NASDAQ

$12.50 0.02 (0.16%)

Market Cap: $1.33B

As of 12/26/23 04:00 PM EST. Market closed.

(PNT)

POINT Biopharma Global Inc. (PNT)
NASDAQ

$12.50
0.02 (0.16%)

Market Cap: $1.33B

As of 12/26/23 04:00 PM EST. Market closed.

Add to Portfolio

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted ... read more

COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Joe A. McCann Ph.D.
Full Time Employees
129
CEO Compensation (Base)
$479,917
CEO Compensation (Total)
$2.84M
URL
Address
4850 West 78th Street, IN, Indianapolis, 46268.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Joe A. McCann Ph.D.
Full Time Employees
129
CEO Compensation (Base)
$479,917
CEO Compensation (Total)
$2.84M
Address
4850 West 78th Street, IN, Indianapolis, 46268.
PRICE CHART FOR POINT BIOPHARMA GLOBAL INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$12.50
Previous Close
$12.48
Days Range
$12.49 - $12.51
52 week range
$6.57 - $14.35
Volume
3,290,875
Avg. Volume (30 days)
3,849,591
Market Cap
$1.33B
Dividend Yield
-
P/E
11.36
Shares Outstanding
106,569,000
Open
$12.50
Previous Close
$12.48
Days Range
$12.49 - $12.51
52 week range
$6.57 - $14.35
Volume
3,290,875
Avg. Volume (30 days)
3,849,591
Market Cap
$1.33B
Dividend Yield
-
P/E
11.36
Shares Outstanding
106,569,000
FINANCIAL STATEMENTS FOR POINT BIOPHARMA GLOBAL INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR POINT BIOPHARMA GLOBAL INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BVF PARTNERS L P/ILFormer 10% OwnerDec 18, 2023 Sale$12.4517,161,278213,657,9080Dec 20, 2023, 06:09 PM
HOGUE GERALD L.DirectorMar 21, 2023 Option Exercise$6.9717,936125,01421,596Mar 23, 2023, 08:09 PM
MCCANN JOE A.Chief Executive OfficerNov 29, 2022 Buy$6.642,16014,3423,616,313Nov 30, 2022, 07:56 PM
Lubner David CharlesDirectorNov 23, 2022 Buy$6.853,60024,6603,600Nov 28, 2022, 04:03 PM
HOGUE GERALD L.DirectorNov 25, 2022 Buy$6.823,66024,9433,660Nov 28, 2022, 04:02 PM
Malik RajeshDirectorNov 28, 2022 Buy$6.663,70024,6423,700Nov 28, 2022, 04:01 PM
MARGOLIN YAELDirectorNov 21, 2022 Buy$6.561,71011,2181,710Nov 23, 2022, 12:43 PM
GOODMAN JONATHAN R.DirectorNov 18, 2022 Buy$6.336,00037,98041,872Nov 21, 2022, 05:54 PM
SILBER ALLAN CExecutive ChairmanNov 18, 2022 Buy$6.5022,397145,5814,268,605Nov 21, 2022, 05:52 PM
SILBER ALLAN CExecutive ChairmanNov 17, 2022 Buy$6.0027,603165,6184,246,208Nov 21, 2022, 05:52 PM
FLESHNER NEIL E.Chief Medical OfficerMay 25, 2022 Sale$7.51564,2044,237,1723,023,045May 26, 2022, 04:05 PM
Kolchinsky PeterChief Executive OfficerJun 29, 2021 Option Exercise$10.00209,1002,091,0001,098,318Jun 30, 2021, 04:31 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJun 29, 2021 Buy$10.00209,1002,091,0001,098,318Jun 30, 2021, 04:30 PM
Kolchinsky PeterChief Executive OfficerJun 24, 2021 Option Exercise$10.00889,2188,892,180889,218Jun 24, 2021, 07:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BVF PARTNERS L P/ILFormer 10% Owner12/18/2023213,657,908
HOGUE GERALD L.Director03/21/2023125,014
MCCANN JOE A.Chief Executive Officer11/29/202214,342
Lubner David CharlesDirector11/23/202224,660
HOGUE GERALD L.Director11/25/202224,943
Malik RajeshDirector11/28/202224,642
MARGOLIN YAELDirector11/21/202211,218
GOODMAN JONATHAN R.Director11/18/202237,980
SILBER ALLAN CExecutive Chairman11/18/2022145,581
SILBER ALLAN CExecutive Chairman11/17/2022165,618
FLESHNER NEIL E.Chief Medical Officer05/25/20224,237,172
Kolchinsky PeterChief Executive Officer06/29/20212,091,000
RA CAPITAL MANAGEMENT, L.P.Director06/29/20212,091,000
Kolchinsky PeterChief Executive Officer06/24/20218,892,180
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR POINT BIOPHARMA GLOBAL INC.
STOCK BUYBACKS FOR POINT BIOPHARMA GLOBAL INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0.06%
1Q
06/30/2023
12/31/2022
-5.15%
2Q
06/30/2023
09/30/2022
14.42%
3Q
06/30/2023
06/30/2022
17.31%
4Q
06/30/2023
03/31/2022
17.31%
5Q
06/30/2023
12/31/2021
43.16%
6Q
06/30/2023
09/30/2021
17.31%
7Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0.06%
1Q
12/31/2022
-5.15%
2Q
09/30/2022
14.42%
3Q
06/30/2022
17.31%
4Q
03/31/2022
17.31%
5Q
12/31/2021
43.16%
6Q
09/30/2021
17.31%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR POINT BIOPHARMA GLOBAL INC.
LOADING...